[go: up one dir, main page]

GB9614366D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9614366D0
GB9614366D0 GBGB9614366.4A GB9614366A GB9614366D0 GB 9614366 D0 GB9614366 D0 GB 9614366D0 GB 9614366 A GB9614366 A GB 9614366A GB 9614366 D0 GB9614366 D0 GB 9614366D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9614366.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
SmithKline Beecham SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham SpA filed Critical SmithKline Beecham SpA
Priority to GBGB9614366.4A priority Critical patent/GB9614366D0/en
Publication of GB9614366D0 publication Critical patent/GB9614366D0/en
Priority to EP97937473A priority patent/EP0912511A1/fr
Priority to PCT/EP1997/003710 priority patent/WO1998001423A1/fr
Priority to JP10504813A priority patent/JP2000514079A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
GBGB9614366.4A 1996-07-09 1996-07-09 Novel compounds Pending GB9614366D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9614366.4A GB9614366D0 (en) 1996-07-09 1996-07-09 Novel compounds
EP97937473A EP0912511A1 (fr) 1996-07-09 1997-07-07 Derives d'acide 5-indolyle-2,4-pentadienoique pouvant etre utilises comme inhibiteurs de la resorption osseuse
PCT/EP1997/003710 WO1998001423A1 (fr) 1996-07-09 1997-07-07 Derives d'acide 5-indolyle-2,4-pentadienoique pouvant etre utilises comme inhibiteurs de la resorption osseuse
JP10504813A JP2000514079A (ja) 1996-07-09 1997-07-07 骨吸収阻害剤として有用な5―インドリル―2,4―ペンタジエン酸誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614366.4A GB9614366D0 (en) 1996-07-09 1996-07-09 Novel compounds

Publications (1)

Publication Number Publication Date
GB9614366D0 true GB9614366D0 (en) 1996-09-04

Family

ID=10796580

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9614366.4A Pending GB9614366D0 (en) 1996-07-09 1996-07-09 Novel compounds

Country Status (4)

Country Link
EP (1) EP0912511A1 (fr)
JP (1) JP2000514079A (fr)
GB (1) GB9614366D0 (fr)
WO (1) WO1998001423A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442366C (fr) * 2001-03-27 2012-09-25 Circagen Pharmaceutical, Llc Inhibiteurs de l'histone deacetylase
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
CA2038925A1 (fr) * 1990-03-26 1991-09-27 Takashi Sohda Derives d'indole; preparation et utilisation
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
SK93297A3 (en) * 1995-01-10 1998-02-04 Smithkline Beecham Spa Indole derivatives, method for their producing, pharmaceutical comosition containing the same, and their use

Also Published As

Publication number Publication date
EP0912511A1 (fr) 1999-05-06
JP2000514079A (ja) 2000-10-24
WO1998001423A1 (fr) 1998-01-15

Similar Documents

Publication Publication Date Title
EP0914330A4 (fr) Composes de type nouveau
EP0904104A4 (fr) Nouveaux composes
EP0954331A4 (fr) Nouveaux composes
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
GB9605381D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
GB9606396D0 (en) Novel compounds
EP0954525A4 (fr) Nouveaux composes
GB9614366D0 (en) Novel compounds
GB9601068D0 (en) Novel compounds
EP0907377A4 (fr) Nouveaux composes
GB9606208D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9605865D0 (en) Novel compounds
GB9605155D0 (en) Novel compounds
GB9606395D0 (en) Novel compounds
GB9615172D0 (en) Novel compounds
GB9606207D0 (en) Novel compounds